September 24, 2025
Title: Unlocking Success: Overcoming Cell & Gene Therapy Challenges with RWE
Wednesday, September 24, 2025
12:00PM EDT | 4:00PM UTC | 6:00PM CEST
Click here for time zone conversion
Registration coming soon
Description
Rapid advancements in cell and gene therapy (CGT) are revolutionizing treatment, offering potential cures for previously untreatable conditions. However, the journey from development to market uptake is fraught with complex challenges and success is not guaranteed. This webinar will delve into critical issues in CGT development planning, exploring regulatory hurdles, new EU HTA and US IRA regulations, payer acceptance, and provider and patient uptake barriers. We will provide actionable solutions supported by real-world evidence (RWE) and real-world data (RWD). Join us to gain strategic insights that will help you navigate the intricate path of CGT development, ensuring successful regulatory approval and market penetration.
Learning Objectives
- Understand how the changing regulatory environment (including EUHTAR and US IRA) is impacting CGT development and ways to plan strategically to address it
- Explore uptake issues, including regulatory, HTA, payer, provider, prescriber, and patient hurdles
- Learn about the applications of real-world data and evidence to the challenges of cell and gene therapy development and uptake
Moderator:
Karen Krewson, BA, Executive Director, Global Market Development, Real-World Evidence, Thermo Fisher Scientific, Waltham, MA, USA
Speakers:
Pedro Saramago Goncalves, MSc, PhD, Research Scientist, Consulting, PPD Evidera Health Economics and Market Access, Thermo Fisher Scientific, London, England, United Kingdom
Martin Parkinson, MRPharmS, Executive Director, Consulting, PPD Evidera Health Economics and Market Access, Thermo Fisher Scientific, London, England, United Kingdom
Amanda Pulfer, BA, Executive Director, Integrated Solutions, RWE PPD Evidera Real-World Data & Scientific Solutions, Thermo Fisher Scientific, London, England, United Kingdom
Heather Gelhorn PhD, Vice President, Science PPD Evidera Patient-Centered Research, Thermo Fisher Scientific, Waltham, MA, USA
Sponsored by Corporate Partner, Thermo Fisher Scientific
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar. Reservations are on a first-come, first-served basis.